The purpose of this trial is to determine the effects (good and bad) temozolomide has on
patients with low-grade glioma. It will also determine whether temozolomide is effective in
preventing or delaying future tumor growth.
Phase:
Phase 2
Details
Lead Sponsor:
Dana-Farber Cancer Institute
Collaborators:
Brigham and Women's Hospital Schering-Plough University of Virginia